Vicks NyQuil Nighttime Cold & Flu

Vicks NyQuil is an iconic over-the-counter medication designed for nighttime relief of cold and flu symptoms. The brand was originally developed by the Richardson-Vicks company, with NyQuil specifically making its debut in the United States in 1966. Its formulation was revolutionary at the time, combining multiple active ingredients to address cough, pain, and congestion in a single liquid dose while promoting rest through its antihistamine component.

In 1985, the parent company Richardson-Vicks was acquired by the consumer goods giant Procter & Gamble (P&G). Since then, P&G has managed the brand's global expansion and distribution. While NyQuil has strong roots in Greensboro, North Carolina, manufacturing is now conducted across several global facilities to meet international demand. For instance, products sold in certain Asian markets are produced in India, while those in North America are often manufactured in the United States.

Today, NyQuil remains a cornerstone of the Vicks portfolio under Procter & Gamble's ownership. The brand has evolved to include various formulations, such as NyQuil Severe and alcohol-free versions, maintaining its status as one of the most trusted multi-symptom cold medicines in the world heading into 2026 and beyond.